1. (a) The OTP shall have written policy and procedure stating any FDA-approved medications for use in treating a significant opioid use disorder when used by an OTP for persons with a history of physiologic dependence, shall only be used in treating persons with a history of symptoms of opioid use disorder as stated in Title 43A, Section 3-601(A) and as verified by the medical director or a program physician through medical examination; or persons with a history of dependence as stated in Title 43A, Section 3-601(A) and written documentation from an agency at which another type of substance use disorder treatment was attempted or accomplished. Such documentation shall be received prior to admission to the program and/or induction of any drug uses as a part of an opioid treatment regimen.

2. (b) The OTP shall have written policy and procedure stating that if clinically appropriate, the program physician may waive the requirement as stated in Title 43A, Section 3-601(A)(2) for:

   1. (1) A person served within six (6) months of release from a correctional institution;
   2. (2) A person served with a pregnancy verified by the program physician; or
   3. (3) A person served having previously received medication-assisted recovery services for an opioid use disorder and within two (2) years of discharge from an OTP.

3. (c) Compliance with 450:70-3-5.1 may be determined by:

   1. (1) A review of policies and procedures,
   2. (2) Treatment records, and
   3. (3) Other facility documentation.

Added at 30 Ok Reg 1425, eff 7-1-13

Amended at 34 Ok Reg 1830, eff 10-1-17

Amended at 40 Ok Reg 1079, eff 9-15-23

Amended at 42 Ok Reg, Number 20, effective 9-1-25